Published in J Pain Res on May 02, 2011
Testing the implementation of an electronic process-of-care checklist for use during morning medical rounds in a tertiary intensive care unit: a prospective before-after study. Ann Intensive Care (2015) 0.83
Effect of using Richmond Agitation Sedation Scale on duration of mechanical ventilation, type and dosage of sedation on hospitalized patients in intensive care units. Iran J Nurs Midwifery Res (2016) 0.78
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med (2000) 11.54
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA (2004) 11.27
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA (2009) 10.24
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med (2002) 9.74
The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med (2002) 9.24
Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA (2003) 6.24
The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest (1998) 5.98
Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med (1999) 4.15
Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology (2006) 4.03
Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med (2006) 3.06
Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology (2007) 2.83
Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med (2005) 2.72
Sedation in the intensive care unit: a systematic review. JAMA (2000) 2.65
Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med (2006) 2.61
Epidemiology of sedation and sedation adequacy for mechanically ventilated patients in a medical and surgical intensive care unit. Crit Care Med (2007) 2.19
Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med (2008) 2.04
Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med (2007) 1.85
Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest (2005) 1.82
A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: a pilot trial. Crit Care Med (2008) 1.71
Patient-focused sedation and analgesia in the ICU. Chest (2008) 1.68
Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ (2002) 1.66
Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med (2008) 1.63
Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med (1992) 1.58
Effect of a nursing-implemented sedation protocol on weaning outcome. Crit Care Med (2008) 1.52
Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med (2000) 1.32
Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med (2005) 1.30
Perceived barriers to the use of sedation protocols and daily sedation interruption: a multidisciplinary survey. J Crit Care (2008) 1.27
Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med (1999) 1.17
Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy (2005) 1.12
Sedation and analgesia in the intensive care unit. Am J Respir Crit Care Med (2002) 1.09
Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm (2007) 1.07
A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy (2000) 1.05
Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med (2012) 2.92
An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med (2013) 2.23
Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm (2013) 2.08
Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med (2002) 1.76
What proportion of vancomycin trough levels are drawn too early?: frequency and impact on clinical actions. Am J Clin Pathol (2012) 1.56
Influence of patients' preferences and treatment site on cancer patients' end-of-life care. Cancer (2010) 1.55
Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care (2009) 1.47
Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. Ann Pharmacother (2005) 1.40
PIES method of critique. Crit Pathw Cardiol (2004) 1.31
Barriers to glucose control in the intensive care unit. Pharmacotherapy (2006) 1.15
Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm (2007) 1.07
Role of dexmedetomidine in adults in the intensive care unit: an update. Am J Health Syst Pharm (2013) 1.03
Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol (2010) 0.95
Azacitidine-induced interstitial and alveolar fibrosis in a patient with myelodysplastic syndrome. Pharmacotherapy (2005) 0.95
Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med (2014) 0.94
Evaluation of compliance with a paper-based, multiplication-factor, intravenous insulin protocol. Ann Pharmacother (2009) 0.86
An intervention to improve the timing of vancomycin levels. Am J Clin Pathol (2013) 0.86
Implementation of a dexmedetomidine stewardship program at a tertiary academic medical center. Ann Pharmacother (2013) 0.84
Etanercept for the Treatment of Transplantation-Related Lung Injury After Hematopoietic Stem Cell Transplantation. Am J Ther (2015) 0.81
Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care (2013) 0.81
Implementation of a Hospital-wide Protocol for Induced Hypothermia Following Successfully Resuscitated Cardiac Arrest. Crit Pathw Cardiol (2010) 0.79
Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure. J Am Coll Cardiol (2002) 0.79
Pharmacodynamic target attainment with high-dose extended-interval tobramycin therapy in patients with cystic fibrosis. J Chemother (2013) 0.77
Error rates among clinical pharmacists in calculating the APACHE II score. Pharmacotherapy (2007) 0.77
Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center. Ther Clin Risk Manag (2013) 0.77
Implementation of clinical pharmacy services in a dialysis unit. Am J Health Syst Pharm (2008) 0.77
Understanding and managing patients with chronic pain. Oral Maxillofac Surg Clin North Am (2010) 0.77
Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications. Am J Health Syst Pharm (2013) 0.76
Antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm (2013) 0.75
Evaluation of the maximum beyond-use-date stability of regular human insulin extemporaneously prepared in 0.9% sodium chloride in a polyvinyl chloride bag. Diabetes Metab Syndr Obes (2013) 0.75
Neuroendocrine derangements in early septic shock: pharmacotherapy for relative adrenal and vasopressin insufficiency. Shock (2017) 0.75
Implementation of a Prolonged Infusion Guideline for Time-Dependent Antimicrobial Agents at a Tertiary Academic Medical Center. Am J Ther (2016) 0.75
Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia. Pharmacotherapy (2013) 0.75
Safety of Propofol for Oxygenator Exchange in Extracorporeal Membrane Oxygenation. ASAIO J (2016) 0.75
Inpatient pharmacological sleep aid utilization is common at a tertiary medical center. J Hosp Med (2014) 0.75
Enhanced responsibilities for pharmacy interns at a teaching hospital. J Am Pharm Assoc (2003) (2015) 0.75
Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol (2016) 0.75
Opening the Door: The Experience of Chronic Critical Illness in a Long-Term Acute Care Hospital. Crit Care Med (2017) 0.75
Evaluation of an institution-wide guideline for hyperglycemic emergencies at a tertiary academic medical center. Ann Pharmacother (2013) 0.75
Conversion to insulin devices in the inpatient setting. Am J Health Syst Pharm (2008) 0.75
Implementation of a journal surveillance program. Am J Health Syst Pharm (2012) 0.75
User-Centered Collaborative Design and Development of an Inpatient Safety Dashboard. Jt Comm J Qual Patient Saf (2017) 0.75